Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival

Julia S Johansen, Klaus Brasso, Peter Iversen, Børge Teisner, Patrick Garnero, Paul A Price, Ib Jarle Christensen

    49 Citationer (Scopus)

    Abstract

    Elevated serum levels of biochemical markers of bone turnover and YKL-40 in patients with metastatic prostate cancer (PC) at the time of diagnosis are associated to poor prognosis. In this study, we evaluated the value of these biomarkers in monitoring the patients during hormonal treatment.
    OriginalsprogEngelsk
    TidsskriftClinical Cancer Research
    Vol/bind13
    Udgave nummer11
    Sider (fra-til)3244-9
    Antal sider6
    ISSN1078-0432
    DOI
    StatusUdgivet - 1 jun. 2007

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival'. Sammen danner de et unikt fingeraftryk.

    Citationsformater